Telenor ASA (TELNY)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21,773	15,279	15,918	13,007	22,016	23,485
Market Cap Growth	35.54%	-4.02%	22.38%	-40.92%	-6.25%	-7.83%
Enterprise Value	31,496	23,385	24,962	25,710	35,533	40,221
Last Close Price	15.83	10.90	10.70	8.15	12.89	13.28
PE Ratio	21.69	9.47	11.75	2.85	126.94	11.61
PS Ratio	2.73	2.17	2.01	1.67	2.00	1.74
PB Ratio	3.15	2.12	2.29	1.99	6.16	4.58
P/TBV Ratio	7.76	4.34	5.39	5.54	-	-
P/FCF Ratio	12.91	9.59	11.22	6.43	8.50	8.11
P/OCF Ratio	7.47	5.51	5.54	3.27	4.59	4.59
EV/Sales Ratio	3.98	3.32	3.15	3.30	3.22	2.98
EV/EBITDA Ratio	9.48	9.88	9.55	9.53	9.56	8.71
EV/EBIT Ratio	16.66	14.69	14.33	15.37	16.13	14.48
EV/FCF Ratio	18.67	14.68	17.59	12.71	13.72	13.89
Debt / Equity Ratio	1.43	1.24	1.50	1.92	4.22	3.45
Debt / EBITDA Ratio	3.02	3.14	3.32	3.94	3.30	3.19
Debt / FCF Ratio	5.86	5.62	7.32	6.20	5.82	6.10
Asset Turnover	0.37	0.36	0.35	0.33	0.40	0.46
Inventory Turnover	30.15	29.75	22.77	17.14	24.05	27.93
Quick Ratio	0.38	0.51	0.75	0.51	0.55	0.67
Current Ratio	0.44	0.59	0.86	0.60	0.71	0.83
Return on Equity (ROE)	16.52%	26.77%	-4.80%	25.76%	23.11%	40.97%
Return on Assets (ROA)	5.25%	5.05%	4.83%	4.43%	5.03%	5.89%
Return on Capital (ROIC)	6.75%	6.29%	6.07%	5.85%	6.75%	7.84%
Return on Capital Employed (ROCE)	11.10%	9.90%	10.20%	8.90%	11.90%	12.10%
Earnings Yield	4.61%	10.56%	8.51%	35.05%	0.79%	8.62%
FCF Yield	7.75%	10.43%	8.92%	15.55%	11.77%	12.33%
Dividend Yield	3.86%	7.75%	8.76%	11.70%	8.19%	7.90%
Payout Ratio	124.70%	71.35%	94.78%	28.98%	824.28%	70.80%
Buyback Yield / Dilution	1.26%	0.80%	0.85%	-	0.59%	2.25%
Total Shareholder Return	5.12%	8.55%	9.61%	11.70%	8.78%	10.16%

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.